C.R. Bard secures $1 billion damages in patent victory
The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard.
Hacon to fill Birss’s shoes at UK court
British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR.
AstraZeneca adds to cancer drug portfolio
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen.
Radcliffe leaves Mayer Brown for Charles Russell
Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP.
Federal Circuit says no to “Prevail” trademark
The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity.
Bayer takes another swipe at Nexavar compulsory licence
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court.
Trevor Cook to leave Bird & Bird for WilmerHale
After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York.
Myriad hit with gene testing suit
US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics.
Dow survives another Bayer patent challenge
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology.
Andrulis sues Celgene over cancer patent
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer.
